CLINICAL RESEARCH: NUCLEAR IMAGING
Positron Emission Tomography-Measured Abnormal Responses of Myocardial Blood Flow to Sympathetic Stimulation Are Associated With the Risk of Developing Cardiovascular Events
Thomas H. Schindler, MD*, ,*,
Egbert U. Nitzsche, MD ,
Heinrich R. Schelbert, MD, PhD*,
Manfred Olschewski, MSc,
James Sayre, PhD*,
Michael Mix, MSc, PhD,
Ingo Brink, MD,
Xiao-Li Zhang, MD, PhD*,
Michael Kreissl, MD*,
Nobuhisa Magosaki, MD,
Hanjoerg Just, MD and
Ulrich Solzbach, MD
* Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California
Division of Cardiology and Nuclear Medicine, and Department for Medical Statistics, University Freiburg, Freiburg, Germany
University of Basel, School of Medicine, Division of Nuclear Medicine, Kantonsspital Aarau, Aarau, Switzerland.
Manuscript received September 26, 2004;
revised manuscript received January 19, 2005,
accepted January 25, 2005.
* Reprint requests and correspondence: Dr. Thomas H. Schindler, Department of Pharmacology, David Geffen School of Medicine at UCLA, B2-045J CHS, Box 956948, Los Angeles, California 90095-6948. (Email: tschindler{at}mednet.ucla.edu).
OBJECTIVES: We sought to assess prospectively whether patients with normal coronary angiograms but with impaired myocardial blood flow (MBF) increases to cold pressor testing (CPT) are at increased risk for cardiovascular events.
BACKGROUND: Invasive angiographic assessments of coronary vasomotor function have demonstrated an impairment of endothelium-related coronary flow increases to independently predict future cardiovascular events. It is unknown whether noninvasive positron emission tomography (PET)-measured MBF alterations to sympathetic stimulation with CPT are associated with the risk of developing cardiovascular events.
METHODS: A total of 72 patients (44 men, 28 women, age 58 ± 8 years) referred for diagnostic cardiac catheterization were studied. Myocardial blood flow was measured in absolute units with 13N-ammonia using PET, at baseline and during CPT in each patient. Cardiovascular events (cardiovascular death, acute coronary syndrome, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, ischemic stroke, or peripheral revascularization) were assessed as clinical outcome parameters over a mean follow-up period of 66 ± 8 months. Patients were assigned to three groups: group 1, patients with  40% increase in MBF (% MBF), n = 22; group 2, patients with >0 and <40% increases in MBF, n = 32; and group 3, patients with decreases in MBF ( 0%), n = 18.
RESULTS: During follow-up, one of the group 1 patients developed a cerebral stroke. In group 2, 15 cardiovascular events occurred in 9 patients and in group 3, 7 patients experienced 9 cardiovascular events (p 0.0001, univariate by log-rank test). Impaired MBF increases in group 2 and group 3 were associated with a significantly higher incidence of cardiovascular events by Kaplan-Meier analysis (p = 0.033, log-rank test). After adjusting for known coronary risk factors, MBF responses to CPT revealed a nonsignificant trend to be independently associated with a higher incidence for cardiovascular events (p = 0.065, multivariate by Cox regression model).
CONCLUSIONS: Noninvasive PET-measured impaired MBF increases to sympathetic stimulation are associated with the risk of developing cardiovascular events.
|
Abbreviations and Acronyms
| | BP = blood pressure | | CPT = cold pressor test | | CVR = coronary vascular resistance | | HR = heart rate | | MBF = myocardial blood flow | | PET = positron emission tomography | | RPP = rate-pressure product | | SPECT = single-photon emission computed tomography |
|
This article has been cited by other articles:
|
|
|
|
 
P. G. Camici and O. E. Rimoldi
The Clinical Value of Myocardial Blood Flow Measurement
J. Nucl. Med.,
July 1, 2009;
50(7):
1076 - 1087.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. M. Bengel, T. Higuchi, M. S. Javadi, and R. Lautamaki
Cardiac positron emission tomography.
J. Am. Coll. Cardiol.,
June 30, 2009;
54(1):
1 - 15.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.G. Nekolla, S. Reder, A. Saraste, T. Higuchi, G. Dzewas, A. Preissel, M. Huisman, T. Poethko, T. Schuster, M. Yu, et al.
Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model
Circulation,
May 5, 2009;
119(17):
2333 - 2342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. R. Schelbert
Coronary circulatory function abnormalities in insulin resistance insights from positron emission tomography.
J. Am. Coll. Cardiol.,
February 3, 2009;
53(5 Suppl):
S3 - S8.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Tio, A. Dabeshlim, H.-M. J. Siebelink, J. de Sutter, H. L. Hillege, C. J. Zeebregts, R. A.J.O. Dierckx, D. J. van Veldhuisen, F. Zijlstra, and R. H.J.A. Slart
Comparison Between the Prognostic Value of Left Ventricular Function and Myocardial Perfusion Reserve in Patients with Ischemic Heart Disease
J. Nucl. Med.,
February 1, 2009;
50(2):
214 - 219.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Neglia and A. L'Abbate
Myocardial Perfusion Reserve in Ischemic Heart Disease
J. Nucl. Med.,
February 1, 2009;
50(2):
175 - 177.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T H Schindler, A D Facta, J O Prior, J Cadenas, W A Hsueh, M J Quinones, and H R Schelbert
Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes
Heart,
March 1, 2007;
93(3):
345 - 349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Graf, A. Khorsand, M. Gwechenberger, C. Novotny, K. Kletter, H. Sochor, C. Pirich, G. Maurer, G. Porenta, and M. Zehetgruber
Typical Chest Pain and Normal Coronary Angiogram: Cardiac Risk Factor Analysis Versus PET for Detection of Microvascular Disease
J. Nucl. Med.,
February 1, 2007;
48(2):
175 - 181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2324 - 2339.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. H. Schindler, J. Cardenas, J. O. Prior, A. D. Facta, M. C. Kreissl, X.-L. Zhang, J. Sayre, M. Dahlbom, J. Licinio, and H. R. Schelbert
Relationship Between Increasing Body Weight, Insulin Resistance, Inflammation, Adipocytokine Leptin, and Coronary Circulatory Function
J. Am. Coll. Cardiol.,
March 21, 2006;
47(6):
1188 - 1195.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Namdar, P. Koepfli, R. Grathwohl, P. T. Siegrist, M. Klainguti, T. Schepis, R. Delaloye, C. A. Wyss, S. P. Fleischmann, O. Gaemperli, et al.
Caffeine Decreases Exercise-Induced Myocardial Flow Reserve
J. Am. Coll. Cardiol.,
January 17, 2006;
47(2):
405 - 410.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas
Highlights of the Year in JACC 2005
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
184 - 202.
[Full Text]
[PDF]
|
|
|
|
